Breast cancer is classified into multiple subtypes, including hormone receptor‐positive (oestrogen/progesterone receptor, ER/PR), HER2‐positive (human epidermal growth factor receptor 2), and triple‐negative breast cancer (TNBC). This evidence concerns the gene ERBB2 and breast carcinoma.